MyAverix Finance
HK · Healthcare
Pharmaron Beijing Co Ltd (3759)
Biotechnology
Pharmaron Beijing Co Ltd (3759) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $34.27B, P/E ratio is 17.11, net margin is 11.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3759
Pharmaron Beijing Co Ltd (3759) — FAQ
What is Pharmaron Beijing Co Ltd's market cap?
Pharmaron Beijing Co Ltd (3759) has a reported market cap of $34.27B (data as of 2026-05-21).
What is 3759's P/E ratio?
The price-to-earnings (P/E) ratio for Pharmaron Beijing Co Ltd (3759) is 17.11 (data as of 2026-05-21).
Does Pharmaron Beijing Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Pharmaron Beijing Co Ltd (3759). Check the MyAverix Finance app for the latest dividend data.
What sector is Pharmaron Beijing Co Ltd in?
Pharmaron Beijing Co Ltd (3759) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3759 listed on?
3759 is listed on HK.
What is Pharmaron Beijing Co Ltd's net margin?
Pharmaron Beijing Co Ltd (3759) reports a net margin of 11.6% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.